Skip to main content
SpringerLink
Log in

Donepezil reduces high cost burden of Alzheimer's disease

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Donepezil reduces high cost burden of Alzheimer's disease. Pharmacoecon. Outcomes News 364, 5 (2002). https://doi.org/10.1007/BF03279108

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03279108

Keywords

Search

Navigation